ClinicalTrials.gov
ClinicalTrials.gov Menu

Pulmonary Hypertension Institutional Registry (RIHP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01501838
Recruitment Status : Suspended (By the moment nvestigators are not recuiting because logistics issues)
First Posted : December 29, 2011
Last Update Posted : March 12, 2018
Sponsor:
Information provided by (Responsible Party):
CRISTINA MARIA ELIZONDO, Hospital Italiano de Buenos Aires

Brief Summary:
The purpose of this study is to create a registry of patients with Pulmonary Hypertension who received medical care in the Hospital Italiano of Buenos Aires.

Condition or disease
Death

Detailed Description:
The Institutional Registry of Pulmonary Hypertension includes patients prospectively with incident pulmonary hypertension, and excludes type II Pulmonary Hypertension. It also includes prevalent cases from our HMO who had diagnosis prior the beginning of the registry.

Study Type : Observational
Estimated Enrollment : 100000 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Pulmonary Hypertension Institutional Registry at Hospital Italiano de Buenos Aires
Study Start Date : December 2010
Estimated Primary Completion Date : December 2020
Estimated Study Completion Date : December 2020

Resource links provided by the National Library of Medicine

U.S. FDA Resources




Primary Outcome Measures :
  1. Pulmonary hypertension prevalence and incidence [ Time Frame: 1 year ]
    The main goal is to describe Pulmonary hypertension prevalence and incidence in our community as well as depict its risk factors, symptoms, prognosis and treatment response.


Secondary Outcome Measures :
  1. Mortality rate [ Time Frame: 1 year ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   17 Years and older   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Adults 17 yo or older, Any type of Pulmonary Hypertension except type II
Criteria

Inclusion Criteria:

  • More 17
  • Pulmonary Hypertension
  • Systolic Pulmonary Pressure >40 mmhg measured in a doppler echocardiogram,
  • Systolic artery pressure <25 in a pulmonary angiography

Exclusion Criteria:

  • Non accept to participate
  • Pulmonary Hypertension type II (Left cardiac disease)

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01501838


Locations
Argentina
Hospital Italiano de Buenos Aires
Buenos Aires, Argentina, 1181
Sponsors and Collaborators
Hospital Italiano de Buenos Aires
Investigators
Principal Investigator: Diego H Giunta, MD Hospital Italiano de Buenos Aires

Responsible Party: CRISTINA MARIA ELIZONDO, Principal Investigator, Hospital Italiano de Buenos Aires
ClinicalTrials.gov Identifier: NCT01501838     History of Changes
Other Study ID Numbers: 1487
First Posted: December 29, 2011    Key Record Dates
Last Update Posted: March 12, 2018
Last Verified: March 2018

Additional relevant MeSH terms:
Hypertension
Hypertension, Pulmonary
Vascular Diseases
Cardiovascular Diseases
Lung Diseases
Respiratory Tract Diseases